| Year |
Citation |
Score |
| 2005 |
Fernandes AW, Madhavan SS, Amonkar MM. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population. Clinical Therapeutics. 27: 630-45. PMID 15978313 DOI: 10.1016/j.clinthera.2005.04.013 |
0.407 |
|
| 2005 |
Fernandes AW, Madhavan SS, Amonkar MM, Bell D, Islam SS, Scott VG. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population. The Annals of Pharmacotherapy. 39: 1416-22. PMID 15972326 DOI: 10.1345/aph.1E560 |
0.396 |
|
| 2004 |
Madhavan SS, Borker RD, Fernandes AW, Amonkar MM, Rosenbluth SA. Assessing predictors of influenza and pneumonia vaccination in rural senior adults. Journal of Health & Social Policy. 18: 13-38. PMID 15447879 DOI: 10.1300/J045V18N04_02 |
0.708 |
|
| 2004 |
Dino G, Kamal K, Horn K, Kalsekar I, Fernandes A. Stage of change and smoking cessation outcomes among adolescents. Addictive Behaviors. 29: 935-40. PMID 15219338 DOI: 10.1016/J.Addbeh.2004.01.004 |
0.645 |
|
| 2004 |
Horn KA, Dino GA, Kalsekar ID, Fernandes AW. Appalachian teen smokers: not on tobacco 15 months later. American Journal of Public Health. 94: 181-4. PMID 14759924 DOI: 10.2105/Ajph.94.2.181 |
0.6 |
|
| 2003 |
Madhavan SS, Borker RD, Fernandes AW, Amonkar MM, Rosenbluth SA. Assessing predictors of influenza and pneumonia vaccination in rural senior adults. Journal of Health & Social Policy. 18: 71-93. PMID 15189797 DOI: 10.1300/J045v18n02_05 |
0.712 |
|
| 2003 |
Horn K, Fernandes A, Dino G, Massey CJ, Kalsekar I. Adolescent nicotine dependence and smoking cessation outcomes. Addictive Behaviors. 28: 769-76. PMID 12726789 DOI: 10.1016/S0306-4603(02)00229-0 |
0.588 |
|
| 2003 |
Madhavan SS, Rosenbluth SA, Amonkar M, Fernandes A, Borker R. Immunization predictors in rural adults under 65 years of age. Journal of Health Care For the Poor and Underserved. 14: 100-21. PMID 12613071 |
0.711 |
|
| 2003 |
Madhavan SS, Rosenbluth SA, Amonkar M, Fernandes A, Borker R. Immunization Predictors in Rural Adults Under 65 Years of Age Journal of Health Care For the Poor and Underserved. 14: 100-121. DOI: 10.1177/1049208902238826 |
0.716 |
|
| 2001 |
Dino GA, Horn KA, Goldcamp J, Maniar SD, Fernandes A, Massey CJ. Statewide demonstration of not on tobacco: a gender-sensitive teen smoking cessation program. The Journal of School Nursing : the Official Publication of the National Association of School Nurses. 17: 90-7. PMID 11885118 DOI: 10.1177/105984050101700206 |
0.363 |
|
| 2001 |
Dino G, Horn K, Goldcamp J, Fernandes A, Kalsekar I, Massey C. A 2-year efficacy study of Not On Tobacco in Florida: an overview of program successes in changing teen smoking behavior. Preventive Medicine. 33: 600-5. PMID 11716656 DOI: 10.1006/Pmed.2001.0932 |
0.37 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2001 |
Fernandes AW, Amonkar MM, Madhavan SS, Nseyo UO. Assessment of urologists' practice preferences for the management of benign prostatic hyperplasia in the Veterans Administration program Current Therapeutic Research - Clinical and Experimental. 62: 129-141. DOI: 10.1016/S0011-393X(01)80022-9 |
0.243 |
|
| 2010 |
Krilov LR, Palazzi DL, Fernandes AW, Klein RW, Mahadevia PJ. Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 77-86. PMID 19706010 DOI: 10.1111/j.1524-4733.2009.00586.x |
0.183 |
|
| 2017 |
Fisher MD, Fernandes A, Olufade TO, Miller PJ, Walker MS, Fenton MJ. Impact of tobacco and alcohol use on HRQOL in patients with advanced head and neck cancer: Results from a community oncology database. Journal of Clinical Oncology. 35: e17512-e17512. DOI: 10.1200/jco.2017.35.15_suppl.e17512 |
0.134 |
|
| 2018 |
Ryan K, Skinner KE, Fernandes A, Walker MS, Pavilack M, Punekar RS, VanderWalde NA. Understanding health-related quality of life (HRQoL) in unresected stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 36: 189-189. DOI: 10.1200/JCO.2018.36.30_suppl.189 |
0.133 |
|
| 2019 |
Ryan KJ, Skinner KE, Fernandes AW, Punekar RS, Pavilack M, Walker MS, VanderWalde NA. Real-world outcomes in patients with unresected stage III non-small cell lung cancer. Medical Oncology (Northwood, London, England). 36: 24. PMID 30706218 DOI: 10.1007/s12032-019-1249-1 |
0.121 |
|
| 2010 |
Frogel MP, Stewart DL, Hoopes M, Fernandes AW, Mahadevia PJ. A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. Journal of Managed Care Pharmacy : Jmcp. 16: 46-58. PMID 20131495 DOI: 10.18553/jmcp.2010.16.1.46 |
0.12 |
|
| 2010 |
Welliver RC, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Current Medical Research and Opinion. 26: 2175-81. PMID 20666690 DOI: 10.1185/03007995.2010.505126 |
0.112 |
|
| 2023 |
Chebib FT, Zhou X, Garbinsky D, Davenport E, Nunna S, Oberdhan D, Fernandes A. Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies. Kidney Medicine. 5: 100639. PMID 37250503 DOI: 10.1016/j.xkme.2023.100639 |
0.11 |
|
| 2011 |
Checchia PA, Nalysnyk L, Fernandes AW, Mahadevia PJ, Xu Y, Fahrbach K, Welliver RC. Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 12: 580-8. PMID 21200358 DOI: 10.1097/PCC.0b013e3182070990 |
0.11 |
|
| 2012 |
Furst DE, Amato AA, Iorga ÅžR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle & Nerve. 45: 676-83. PMID 22499094 DOI: 10.1002/mus.23302 |
0.108 |
|
| 2018 |
Nadler E, Fernandes A, Pavilack M, Amirian S, Clark J, Frytak JR. Understanding epidermal growth factor receptor mutation (EGFRm) testing in patients (pts) with non-small cell lung cancer (NSCLC) in a large community oncology network. Journal of Clinical Oncology. 36: 9-9. DOI: 10.1200/JCO.2018.36.30_suppl.9 |
0.102 |
|
| 2019 |
Bobbili P, Ryan K, Duh MS, Dua A, Fernandes AW, Pavilack M, Gomez JE. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer. Future Oncology (London, England). PMID 31544510 DOI: 10.2217/fon-2019-0282 |
0.101 |
|
| 2013 |
Furst DE, Clarke AE, Fernandes AW, Bancroft T, Greth W, Iorga SR. Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus. 22: 99-105. PMID 23042822 DOI: 10.1177/0961203312463110 |
0.1 |
|
| 2019 |
Ryan KJ, Skinner KE, Fernandes AW, Punekar RS, Pavilack M, Walker MS, VanderWalde NA. Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancer. Future Oncology (London, England). PMID 31037966 DOI: 10.2217/fon-2018-0939 |
0.099 |
|
| 2020 |
Nadler E, Espirito JL, Pavilack M, Baidoo B, Fernandes A. Real-world disease burden and outcomes of brain metastases in mutation-positive non-small-cell lung cancer. Future Oncology (London, England). 16: 1575-1584. PMID 32495656 DOI: 10.2217/fon-2020-0280 |
0.092 |
|
| 2012 |
Smoyer-Tomic KE, Amato AA, Fernandes AW. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis. Bmc Musculoskeletal Disorders. 13: 103. PMID 22703603 DOI: 10.1186/1471-2474-13-103 |
0.091 |
|
| 2009 |
Stewart DL, Romero JR, Buysman EK, Fernandes AW, Mahadevia PJ. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention. Current Medical Research and Opinion. 25: 2795-804. PMID 19788406 DOI: 10.1185/03007990903290894 |
0.085 |
|
| 2017 |
Turner RM, Chen YW, Fernandes AW. Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases. Frontiers in Pharmacology. 8: 883. PMID 29249970 DOI: 10.3389/fphar.2017.00883 |
0.084 |
|
| 2012 |
Tomic K, Amato A, Fernandes A. PSY10 Incidence and Prevalence of Idiopathic Inflammatory Myopathies Among Commercially Insured, Medicare Supplemental Insured, and Medicaid Enrolled Populations Value in Health. 15: A100. DOI: 10.1016/j.jval.2012.03.544 |
0.084 |
|
| 2010 |
Romero JR, Stewart DL, Buysman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants. Clinical Therapeutics. 32: 2422-32. PMID 21353110 DOI: 10.1016/j.clinthera.2011.01.007 |
0.084 |
|
| 2011 |
Slawsky KA, Fernandes AW, Fusfeld L, Manzi S, Goss TF. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care & Research. 63: 1224-32. PMID 21584945 DOI: 10.1002/acr.20502 |
0.083 |
|
| 2005 |
Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia. Managed Care Interface. 18: 36-44. PMID 16265933 |
0.081 |
|
| 2017 |
Skinner KE, Fernandes A, Walker MS, Pavilack M, Vanderwalde AM. Patient-reported outcomes in patients with NSCLC who progress on 1st-/2nd-generation EGFR TKIs. Journal of Clinical Oncology. 35: e20590-e20590. DOI: 10.1200/jco.2017.35.15_suppl.e20590 |
0.076 |
|
| 2017 |
Nadler ES, Espirito JL, Pavilack M, Boyd M, Vergara-Silva AL, Fernandes A. Understanding treatment patterns and outcomes in patients with metastatic NSCLC treated in a US community oncology network. Journal of Clinical Oncology. 35: e20643-e20643. DOI: 10.1200/jco.2017.35.15_suppl.e20643 |
0.071 |
|
| 2017 |
Fernandes A, Skinner KE, Walker MS, Pavilack M, Vanderwalde AM. Understanding real-world outcomes in patients with NSCLC who progress on 1st-/2nd-generation EGFR TKIs. Journal of Clinical Oncology. 35: e20589-e20589. DOI: 10.1200/JCO.2017.35.15_SUPPL.E20589 |
0.07 |
|
| 2019 |
Kelly RJ, Turner R, Chen YW, Rigas JR, Fernandes AW, Karve S. Complications and Economic Burden Associated With Obtaining Tissue for Diagnosis and Molecular Analysis in Patients With Non-Small-Cell Lung Cancer in the United States. Journal of Oncology Practice. JOP1800762. PMID 31237806 DOI: 10.1200/JOP.18.00762 |
0.069 |
|
| 2017 |
Bookman MA, Tyczynski JE, Espirito JL, Wilson TW, Fernandes AW. Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer. Gynecologic Oncology. PMID 28454659 DOI: 10.1016/j.ygyno.2017.04.011 |
0.069 |
|
| 2005 |
Lester JW, Fernandes AW. Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome International Journal of Clinical Practice. 59: 134-142. PMID 15854187 DOI: 10.1111/j.1742-1241.2005.00459.x |
0.067 |
|
| 2019 |
Bridges JF, la Cruz M, Pavilack M, Flood E, Janssen EM, Chehab N, Fernandes AW. Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer. Future Oncology (London, England). PMID 31621403 DOI: 10.2217/fon-2019-0396 |
0.066 |
|
| 2015 |
Turner RM, Croft E, Chen Y, Tunceli O, Elesinmogun C, Fernandes A. Statistical Assessment of a Case-Finding Algorithm for Identifying Non-Small Cell Lung Cancer (Nsclc) Patients in Administrative Claims Databases. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A722. PMID 26534046 DOI: 10.1016/j.jval.2015.09.2742 |
0.064 |
|
| 2016 |
Kim E, Dinan M, Islam KM, Fernandes A, Schwartzberg L, Croft E, Brahmer J, Mansfield A, Hyslop T, Burke L, Crawford J. PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S308-S309. PMID 27969528 DOI: 10.1016/J.Jtho.2016.09.096 |
0.064 |
|
| 2013 |
Petri M, Kawata AK, Fernandes AW, Gajria K, Greth W, Hareendran A, Ethgen D. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus. The Journal of Rheumatology. 40: 1865-74. PMID 24085548 DOI: 10.3899/jrheum.130046 |
0.061 |
|
| 2019 |
Nadler E, Pavilack M, Clark J, Espirito J, Fernandes A. Biomarker Testing Rates in Patients with Advanced Non-Small Cell Lung Cancer Treated in the Community Journal of Cancer Therapy. 10: 971-984. DOI: 10.4236/jct.2019.1012083 |
0.061 |
|
| 2018 |
Fisher MD, Fernandes AW, Olufade TO, Miller PJ, Walker MS, Fenton M. Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database. Clinical Therapeutics. PMID 30150077 DOI: 10.1016/j.clinthera.2018.07.016 |
0.06 |
|
| 2013 |
Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W, Iorga SR. Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population. Lupus. 22: 268-78. PMID 23340996 DOI: 10.1177/0961203312474087 |
0.06 |
|
| 2017 |
Siddiqui MK, Tyczynski J, Pahwa A, Fernandes AW. Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer. Gynecologic Oncology. PMID 28395896 DOI: 10.1016/j.ygyno.2017.03.515 |
0.06 |
|
| 2018 |
Subramanian J, Laliberté F, Fernandes A, Pavilack M, Jacques P, Duh M. P2.15-26 Rates and Economic Burden of Adverse Events in Patients With Metastatic NSCLC Treated with EGFR-TKIs Journal of Thoracic Oncology. 13: S827. DOI: 10.1016/j.jtho.2018.08.1468 |
0.059 |
|
| 2018 |
Nadler E, Espirito JL, Pavilack M, Boyd M, Vergara-Silva A, Fernandes A. Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting. Clinical Lung Cancer. PMID 29576407 DOI: 10.1016/j.cllc.2018.02.002 |
0.057 |
|
| 2019 |
Subramanian J, Fernandes AW, Laliberté F, Pavilack M, DerSarkissian M, Duh MS. The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors. Lung Cancer (Amsterdam, Netherlands). 138: 131-138. PMID 31733614 DOI: 10.1016/j.lungcan.2019.07.021 |
0.056 |
|
| 2006 |
Jackson J, Fernandes AW, Nelson W. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis. Clinical Therapeutics. 28: 1462-71. PMID 17062318 DOI: 10.1016/j.clinthera.2006.09.018 |
0.056 |
|
| 2017 |
Skinner KE, Fernandes AW, Walker MS, Pavilack M, VanderWalde A. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study. Journal of Medical Economics. 1-9. PMID 29041833 DOI: 10.1080/13696998.2017.1389744 |
0.051 |
|
| 2019 |
Lejeune D, Pavilack M, Dersarkissian M, Fernandes A, Duh M, Subramanian J. PCN48 ECONOMIC BURDEN ASSOCIATED WITH SEVERE ADVERSE EVENTS IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS Value in Health. 22: S64-S65. DOI: 10.1016/J.JVAL.2019.04.172 |
0.05 |
|
| 2012 |
Furst DE, Fernandes AW, Iorga SR, Greth W, Bancroft T. Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population. The Journal of Rheumatology. 39: 2303-9. PMID 23027885 DOI: 10.3899/jrheum.120600 |
0.048 |
|
| 2019 |
Nadler E, Pavilack M, Clark J, Espirito J, Fernandes A. P1.16-36 Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting Journal of Thoracic Oncology. 14: S601. DOI: 10.1016/j.jtho.2019.08.1262 |
0.047 |
|
| 2013 |
Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W, Iorga SR. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population. Journal of Medical Economics. 16: 500-9. PMID 23363329 DOI: 10.3111/13696998.2013.772058 |
0.044 |
|
| 2017 |
Fernandes AW, Wu B, Turner RM. Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden. Journal of Medical Economics. 1-30. PMID 28758857 DOI: 10.1080/13696998.2017.1361960 |
0.044 |
|
| 2023 |
Lioudis M, Zhou X, Davenport E, Nunna S, Krasa HB, Oberdhan D, Fernandes AW. Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis. Bmc Nephrology. 24: 182. PMID 37349694 DOI: 10.1186/s12882-023-03247-6 |
0.044 |
|
| 2018 |
Fisher MD, Fernandes AW, Olufade TO, Miller PJ, Walker MS, Fenton M. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database. Clinical Therapeutics. PMID 29530457 DOI: 10.1016/j.clinthera.2018.02.010 |
0.042 |
|
| 2018 |
Nadler E, Pavilack M, Espirito J, Baidoo B, Fernandes A. MA08.06 Outcomes Among Patients with EGFR-Mutant Metastatic NSCLC with and without Brain Metastases Journal of Thoracic Oncology. 13: S383. DOI: 10.1016/j.jtho.2018.08.380 |
0.041 |
|
| 2016 |
Unni SK, Schauerhamer MB, Deka R, Tyczynski JE, Fernandes AW, Stevens V, Brixner DI, Stenehjem DD. BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study. Journal of Ovarian Research. 9: 18. PMID 27004793 DOI: 10.1186/s13048-016-0227-x |
0.041 |
|
| 2018 |
Chiang A, Fernandes A, Pavilack M, Wu J, Laliberté F, Duh M, Chehab N, Subramanian J. MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR-TKIs Journal of Thoracic Oncology. 13: S410-S411. DOI: 10.1016/J.JTHO.2018.08.447 |
0.039 |
|
| 2013 |
Kosinski M, Gajria K, Fernandes AW, Cella D. Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus. Lupus. 22: 422-30. PMID 23423250 DOI: 10.1177/0961203313476360 |
0.037 |
|
| 2012 |
Furst DE, Fernandes AW, Iorga SR, Greth W, Bancroft T. Epidemiology of systemic sclerosis in a large US managed care population. The Journal of Rheumatology. 39: 784-6. PMID 22382343 DOI: 10.3899/jrheum.111106 |
0.037 |
|
| 2017 |
Karve S, Turner R, Chen Y, Rigas J, Fernandes A, Kelly R. P3.07-002 Complications and Costs of Diagnostic and Post-Progression Biopsies among Patients with Non-Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology. 12: S1431. DOI: 10.1016/j.jtho.2016.11.2193 |
0.035 |
|
| 2012 |
Furst DE, Amato AA, Iorga SR, Bancroft T, Fernandes AW. Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population. Muscle & Nerve. 46: 496-505. PMID 22987689 DOI: 10.1002/mus.23384 |
0.035 |
|
| 2011 |
Krilov L, Palazzi D, Fernandes AW, Klein R, Mahadevia PJ. The value of budget impact analyses in evaluating targeted therapies-The case of RSV prophylaxis for preterm infants. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 201-2. PMID 21211503 DOI: 10.1016/j.jval.2010.10.001 |
0.035 |
|
| 2020 |
Chiang AC, Fernandes AW, Pavilack M, Wu JW, Laliberté F, Duh MS, Chehab N, Subramanian J. EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors. Bmc Cancer. 20: 356. PMID 32345265 DOI: 10.1186/s12885-020-06826-0 |
0.033 |
|
| 2016 |
Fernandes AW, Kern DM, Datto C, Chen YW, McLeskey C, Tunceli O. Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain. American Health & Drug Benefits. 9: 160-70. PMID 27606040 |
0.029 |
|
| 2020 |
Nadler E, Pavilack M, Espirito JL, Clark J, Fernandes A. Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors. Advances in Therapy. PMID 31955357 DOI: 10.1007/s12325-020-01221-4 |
0.027 |
|
| 2016 |
Bookman MA, Tyczynski JE, Espirito JL, Wilson T, Fernandes A. Sustained impact of primary platinum-free interval and BRCA1/2 mutation status on survival in patients with ovarian cancer after multiple lines of therapy. Journal of Clinical Oncology. 34: 5566-5566. DOI: 10.1200/jco.2016.34.15_suppl.5566 |
0.023 |
|
| 2004 |
Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Clinical Therapeutics. 26: 1400-10. PMID 15531002 DOI: 10.1016/j.clinthera.2004.09.016 |
0.022 |
|
| 2018 |
Bridges J, De La Cruz M, Pavilack M, Flood E, Janssen E, Chehab N, Fernandes A. OA10.01 Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC Journal of Thoracic Oncology. 13: S343. DOI: 10.1016/j.jtho.2018.08.288 |
0.021 |
|
| 2024 |
Betts KA, Nunna S, Kumar R, Nie X, Fernandes AW. Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease. Kidney Medicine. 6: 100802. PMID 38562967 DOI: 10.1016/j.xkme.2024.100802 |
0.014 |
|
| 2017 |
Bookman M, Espirito J, Wilson T, Fernandes A. Chemotherapy costs, but not resource utilization, are inversely correlated with the primary platinum-free interval among outpatients with recurrent ovarian cancer Gynecologic Oncology. 145: 170-171. DOI: 10.1016/j.ygyno.2017.03.390 |
0.01 |
|
| Hide low-probability matches. |